ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CTI Cathay International Holdings Ld

0.75
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cathay International Holdings Ld LSE:CTI London Ordinary Share BMG1965E1030 COM SHS $0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.75 0.50 1.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cathay International Holdings Ld Renewal of Cross Guarantee (0767Y)

03/05/2019 2:24pm

UK Regulatory


Cathay International Hol... (LSE:CTI)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Cathay International Hol... Charts.

TIDMCTI

RNS Number : 0767Y

Cathay International Holdings Ld

03 May 2019

Cathay International Holdings Limited ("Cathay" or the "Company")

Renewal of Cross Guarantee Agreement

between Jilin Haizi and Lansen's subsidiaries

Hong Kong, 3 May 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, today announces the proposed renewal of a cross guarantee agreement first entered into in June 2016 between Jilin Haizi Bio-Engineering Technology Company Ltd ("Jilin Haizi"), (a wholly owned subsidiary of the Company), Ningbo Liwah Pharmaceutical Company Ltd ("Ningbo Liwah") (a wholly owned subsidiary of Lansen Pharmaceutical Holdings Ltd ("Lansen" (HKEX: 503), in which the Company has a 50.68% holding)) and Lansen BVI (also a wholly owned subsidiary of Lansen).

The 2016 Cross Guarantee Agreement will expire on 30 June 2019 and, therefore, Ningbo Liwah, Jilin Haizi and Lansen BVI have entered into the 2019 Cross Guarantee Agreement, subject to the approval of Lansen's independent shareholders pursuant to the requirements of the Hong Kong Listing Rules.

The terms of the 2019 Cross Guarantee Agreement are unchanged from the 2016 Cross Guarantee Agreement save that it will be valid from 1 July 2019 to 30 June 2022 (the "Term"). Under the terms of the 2019 Cross Guarantee Agreement and during the Term, Jilin Haizi has agreed to provide guarantees in respect of obligations of Ningbo Liwah in respect of bank facilities obtained or to be obtained by Ningbo Liwah (the "Jilin Haizi Guarantees"). On a reciprocal basis, Lansen BVI has agreed to procure that its subsidiary, as appropriate, provide guarantees in respect of obligations of Jilin Haizi under the bank facilities to be obtained by Jilin Haizi (the "Lansen BVI Guarantees") (the Jilin Haizi Guarantees and the Lansen BVI Guarantees, collectively, the "Guarantees").

During the Term, the total amount of the Jilin Haizi Guarantees contemplated under the Cross Guarantee Agreement shall not exceed RMB130,000,000 (USD19.3 million); and, on a reciprocal basis, the total amount of the Lansen BVI Guarantees contemplated under the Cross Guarantee Agreement shall not exceed RMB130,000,000 (USD19.3 million). The Guarantees are unsecured.

The bank loans to be borrowed by the parties and covered by the Guarantees should be used solely for the purpose of meeting the funding requirement of each of the parties in their ordinary course of business.

The directors of the Company are satisfied that the 2019 Cross Guarantee Agreement is on normal commercial terms.

The full text of the Lansen Announcement can be found at http://www3.hkexnews.hk/listedco/listconews/SEHK/2019/0503/LTN201905031549.pdf and will also be made available at the Announcements & Notices section of Lansen's homepage at http://holding.lansen.com.cn/en/newslist.aspx?NodeCode=10002000700050005.

- ENDS -

For further enquiries, please contact:

Cathay International Holdings Limited

Eric Siu (Finance Director) Tel: +852 2828 9289

Patrick Sung (Director and Controller)

Consilium Strategic Communications

Mary-Jane Elliott/ Matthew Neal / Lindsey Neville Tel: +44 (0) 203 709 5700

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Group aims to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a PRC specialty pharmaceutical company focused on rheumatology and dermatology; Haizi, a PRC inositol manufacturer; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 1,600 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment in Shenzhen. For more information please visit the Company's website: http://www.cathay-intl.com.hk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

AGRLLFFVEIIVIIA

(END) Dow Jones Newswires

May 03, 2019 09:24 ET (13:24 GMT)

1 Year Cathay International Hol... Chart

1 Year Cathay International Hol... Chart

1 Month Cathay International Hol... Chart

1 Month Cathay International Hol... Chart

Your Recent History

Delayed Upgrade Clock